-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Mobilizing Full Production Capacity to Strive for a Strong Start
Category:
发布时间：2026-01-12
【概要描述】
At the start of the new year, Shijiazhuang Sihua Pharmaceutical Group has adopted a “start with a sprint” approach, seizing favorable opportunities such as winning bids in centralized procurement and growing market demand to ramp up production and ensure supply. The company is making all-out efforts to lay a solid foundation for a strong start, a successful launch, and improved quality and efficiency in the new year, striving to achieve a robust performance in the first month.
At the start of the new year, Shijiazhuang Sihua Pharmaceutical Group has adopted a “start with a sprint” approach, seizing favorable opportunities such as winning bids in centralized procurement and growing market demand to ramp up production and ensure supply. The company is making all-out efforts to lay a solid foundation for a strong start, a promising beginning, and improved quality and efficiency in the new year, striving to achieve a robust performance in the first month.
On January 9, all production lines for oral formulations and intravenous solutions at the group operated at full capacity to meet market demand.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091